Click here for printable version

4th January 2005

Elan to Present at the Morgan Stanley Pharmaceutical CEO's Unplugged Conference

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 4, 2005--Elan Corporation, plc announces that it will present at the Morgan Stanley Pharmaceutical CEO's Unplugged Conference in New York on Thursday, January 6, 2005 at 8:45 a.m. Eastern Standard Time, 1:45 p.m. Greenwich Mean Time. Interested parties may access a live audio webcast of the presentation by visiting Elan's website at www.elan.com and clicking on the Investor Relations section, then on the event icon.

About Elan

Elan is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing, selling and marketing advanced therapies in neurodegenerative diseases, autoimmune diseases and severe pain. Elan's (NYSE: ELN) shares trade on the New York, London and Dublin Stock Exchanges.

CONTACT: Elan Corporation, plc
Investors:
Emer Reynolds, 353-1-709-4000 / 800-252-3526
or
Media:
Anita Kawatra, 212-407-5740 / 800-252-3526

SOURCE: Elan Corporation, plc


Click here for printable version